Effect of Tegafur-Uracil in Resected Stage IB Lung Adenocarcinoma According to Presence or Absence of Epidermal Growth Factor Receptor Gene Mutation: A Retrospective Cohort Study
CONCLUSION: UFT administration can improve the prognosis of EGFR mutation-negative LUAD but not EGFR mutation-positive LUAD. Thus, clinical trials of adjuvant-targeted therapy for EGFR mutation-positive stage IB LUAD should also be conducted in Japan.PMID:38105006 | DOI:10.5761/atcs.oa.23-00134 (Source: Annals of Thoracic and Cardiovascular Surgery)
Source: Annals of Thoracic and Cardiovascular Surgery - December 17, 2023 Category: Cardiovascular & Thoracic Surgery Authors: Masaya Aoki Ryo Miyata Go Kamimura Aya Harada Takeda Takayuki Suetsugu Keiko Mizuno Kazuhiro Ueda Source Type: research

Effect of Tegafur-Uracil in Resected Stage IB Lung Adenocarcinoma According to Presence or Absence of Epidermal Growth Factor Receptor Gene Mutation: A Retrospective Cohort Study
CONCLUSION: UFT administration can improve the prognosis of EGFR mutation-negative LUAD but not EGFR mutation-positive LUAD. Thus, clinical trials of adjuvant-targeted therapy for EGFR mutation-positive stage IB LUAD should also be conducted in Japan.PMID:38105006 | DOI:10.5761/atcs.oa.23-00134 (Source: Annals of Thoracic and Cardiovascular Surgery)
Source: Annals of Thoracic and Cardiovascular Surgery - December 17, 2023 Category: Cardiovascular & Thoracic Surgery Authors: Masaya Aoki Ryo Miyata Go Kamimura Aya Harada Takeda Takayuki Suetsugu Keiko Mizuno Kazuhiro Ueda Source Type: research

Effect of Tegafur-Uracil in Resected Stage IB Lung Adenocarcinoma According to Presence or Absence of Epidermal Growth Factor Receptor Gene Mutation: A Retrospective Cohort Study
CONCLUSION: UFT administration can improve the prognosis of EGFR mutation-negative LUAD but not EGFR mutation-positive LUAD. Thus, clinical trials of adjuvant-targeted therapy for EGFR mutation-positive stage IB LUAD should also be conducted in Japan.PMID:38105006 | DOI:10.5761/atcs.oa.23-00134 (Source: Annals of Thoracic and Cardiovascular Surgery)
Source: Annals of Thoracic and Cardiovascular Surgery - December 17, 2023 Category: Cardiovascular & Thoracic Surgery Authors: Masaya Aoki Ryo Miyata Go Kamimura Aya Harada Takeda Takayuki Suetsugu Keiko Mizuno Kazuhiro Ueda Source Type: research

Effect of Tegafur-Uracil in Resected Stage IB Lung Adenocarcinoma According to Presence or Absence of Epidermal Growth Factor Receptor Gene Mutation: A Retrospective Cohort Study
CONCLUSION: UFT administration can improve the prognosis of EGFR mutation-negative LUAD but not EGFR mutation-positive LUAD. Thus, clinical trials of adjuvant-targeted therapy for EGFR mutation-positive stage IB LUAD should also be conducted in Japan.PMID:38105006 | DOI:10.5761/atcs.oa.23-00134 (Source: Annals of Thoracic and Cardiovascular Surgery)
Source: Annals of Thoracic and Cardiovascular Surgery - December 17, 2023 Category: Cardiovascular & Thoracic Surgery Authors: Masaya Aoki Ryo Miyata Go Kamimura Aya Harada Takeda Takayuki Suetsugu Keiko Mizuno Kazuhiro Ueda Source Type: research

Effect of Tegafur-Uracil in Resected Stage IB Lung Adenocarcinoma According to Presence or Absence of Epidermal Growth Factor Receptor Gene Mutation: A Retrospective Cohort Study
CONCLUSION: UFT administration can improve the prognosis of EGFR mutation-negative LUAD but not EGFR mutation-positive LUAD. Thus, clinical trials of adjuvant-targeted therapy for EGFR mutation-positive stage IB LUAD should also be conducted in Japan.PMID:38105006 | DOI:10.5761/atcs.oa.23-00134 (Source: Annals of Thoracic and Cardiovascular Surgery)
Source: Annals of Thoracic and Cardiovascular Surgery - December 17, 2023 Category: Cardiovascular & Thoracic Surgery Authors: Masaya Aoki Ryo Miyata Go Kamimura Aya Harada Takeda Takayuki Suetsugu Keiko Mizuno Kazuhiro Ueda Source Type: research

Effect of Tegafur-Uracil in Resected Stage IB Lung Adenocarcinoma According to Presence or Absence of Epidermal Growth Factor Receptor Gene Mutation: A Retrospective Cohort Study
CONCLUSION: UFT administration can improve the prognosis of EGFR mutation-negative LUAD but not EGFR mutation-positive LUAD. Thus, clinical trials of adjuvant-targeted therapy for EGFR mutation-positive stage IB LUAD should also be conducted in Japan.PMID:38105006 | DOI:10.5761/atcs.oa.23-00134 (Source: Annals of Thoracic and Cardiovascular Surgery)
Source: Annals of Thoracic and Cardiovascular Surgery - December 17, 2023 Category: Cardiovascular & Thoracic Surgery Authors: Masaya Aoki Ryo Miyata Go Kamimura Aya Harada Takeda Takayuki Suetsugu Keiko Mizuno Kazuhiro Ueda Source Type: research

Effect of Tegafur-Uracil in Resected Stage IB Lung Adenocarcinoma According to Presence or Absence of Epidermal Growth Factor Receptor Gene Mutation: A Retrospective Cohort Study
CONCLUSION: UFT administration can improve the prognosis of EGFR mutation-negative LUAD but not EGFR mutation-positive LUAD. Thus, clinical trials of adjuvant-targeted therapy for EGFR mutation-positive stage IB LUAD should also be conducted in Japan.PMID:38105006 | DOI:10.5761/atcs.oa.23-00134 (Source: Annals of Thoracic and Cardiovascular Surgery)
Source: Annals of Thoracic and Cardiovascular Surgery - December 17, 2023 Category: Cardiovascular & Thoracic Surgery Authors: Masaya Aoki Ryo Miyata Go Kamimura Aya Harada Takeda Takayuki Suetsugu Keiko Mizuno Kazuhiro Ueda Source Type: research

Effect of Tegafur-Uracil in Resected Stage IB Lung Adenocarcinoma According to Presence or Absence of Epidermal Growth Factor Receptor Gene Mutation: A Retrospective Cohort Study
CONCLUSION: UFT administration can improve the prognosis of EGFR mutation-negative LUAD but not EGFR mutation-positive LUAD. Thus, clinical trials of adjuvant-targeted therapy for EGFR mutation-positive stage IB LUAD should also be conducted in Japan.PMID:38105006 | DOI:10.5761/atcs.oa.23-00134 (Source: Annals of Thoracic and Cardiovascular Surgery)
Source: Annals of Thoracic and Cardiovascular Surgery - December 17, 2023 Category: Cardiovascular & Thoracic Surgery Authors: Masaya Aoki Ryo Miyata Go Kamimura Aya Harada Takeda Takayuki Suetsugu Keiko Mizuno Kazuhiro Ueda Source Type: research

Effect of Tegafur-Uracil in Resected Stage IB Lung Adenocarcinoma According to Presence or Absence of Epidermal Growth Factor Receptor Gene Mutation: A Retrospective Cohort Study
CONCLUSION: UFT administration can improve the prognosis of EGFR mutation-negative LUAD but not EGFR mutation-positive LUAD. Thus, clinical trials of adjuvant-targeted therapy for EGFR mutation-positive stage IB LUAD should also be conducted in Japan.PMID:38105006 | DOI:10.5761/atcs.oa.23-00134 (Source: Annals of Thoracic and Cardiovascular Surgery)
Source: Annals of Thoracic and Cardiovascular Surgery - December 17, 2023 Category: Cardiovascular & Thoracic Surgery Authors: Masaya Aoki Ryo Miyata Go Kamimura Aya Harada Takeda Takayuki Suetsugu Keiko Mizuno Kazuhiro Ueda Source Type: research

Effect of Tegafur-Uracil in Resected Stage IB Lung Adenocarcinoma According to Presence or Absence of Epidermal Growth Factor Receptor Gene Mutation: A Retrospective Cohort Study
CONCLUSION: UFT administration can improve the prognosis of EGFR mutation-negative LUAD but not EGFR mutation-positive LUAD. Thus, clinical trials of adjuvant-targeted therapy for EGFR mutation-positive stage IB LUAD should also be conducted in Japan.PMID:38105006 | DOI:10.5761/atcs.oa.23-00134 (Source: Annals of Thoracic and Cardiovascular Surgery)
Source: Annals of Thoracic and Cardiovascular Surgery - December 17, 2023 Category: Cardiovascular & Thoracic Surgery Authors: Masaya Aoki Ryo Miyata Go Kamimura Aya Harada Takeda Takayuki Suetsugu Keiko Mizuno Kazuhiro Ueda Source Type: research

Effect of Tegafur-Uracil in Resected Stage IB Lung Adenocarcinoma According to Presence or Absence of Epidermal Growth Factor Receptor Gene Mutation: A Retrospective Cohort Study
CONCLUSION: UFT administration can improve the prognosis of EGFR mutation-negative LUAD but not EGFR mutation-positive LUAD. Thus, clinical trials of adjuvant-targeted therapy for EGFR mutation-positive stage IB LUAD should also be conducted in Japan.PMID:38105006 | DOI:10.5761/atcs.oa.23-00134 (Source: Annals of Thoracic and Cardiovascular Surgery)
Source: Annals of Thoracic and Cardiovascular Surgery - December 17, 2023 Category: Cardiovascular & Thoracic Surgery Authors: Masaya Aoki Ryo Miyata Go Kamimura Aya Harada Takeda Takayuki Suetsugu Keiko Mizuno Kazuhiro Ueda Source Type: research

Effect of Tegafur-Uracil in Resected Stage IB Lung Adenocarcinoma According to Presence or Absence of Epidermal Growth Factor Receptor Gene Mutation: A Retrospective Cohort Study
CONCLUSION: UFT administration can improve the prognosis of EGFR mutation-negative LUAD but not EGFR mutation-positive LUAD. Thus, clinical trials of adjuvant-targeted therapy for EGFR mutation-positive stage IB LUAD should also be conducted in Japan.PMID:38105006 | DOI:10.5761/atcs.oa.23-00134 (Source: Annals of Thoracic and Cardiovascular Surgery)
Source: Annals of Thoracic and Cardiovascular Surgery - December 17, 2023 Category: Cardiovascular & Thoracic Surgery Authors: Masaya Aoki Ryo Miyata Go Kamimura Aya Harada Takeda Takayuki Suetsugu Keiko Mizuno Kazuhiro Ueda Source Type: research

Effect of Tegafur-Uracil in Resected Stage IB Lung Adenocarcinoma According to Presence or Absence of Epidermal Growth Factor Receptor Gene Mutation: A Retrospective Cohort Study
CONCLUSION: UFT administration can improve the prognosis of EGFR mutation-negative LUAD but not EGFR mutation-positive LUAD. Thus, clinical trials of adjuvant-targeted therapy for EGFR mutation-positive stage IB LUAD should also be conducted in Japan.PMID:38105006 | DOI:10.5761/atcs.oa.23-00134 (Source: Annals of Thoracic and Cardiovascular Surgery)
Source: Annals of Thoracic and Cardiovascular Surgery - December 17, 2023 Category: Cardiovascular & Thoracic Surgery Authors: Masaya Aoki Ryo Miyata Go Kamimura Aya Harada Takeda Takayuki Suetsugu Keiko Mizuno Kazuhiro Ueda Source Type: research

Effect of Tegafur-Uracil in Resected Stage IB Lung Adenocarcinoma According to Presence or Absence of Epidermal Growth Factor Receptor Gene Mutation: A Retrospective Cohort Study
CONCLUSION: UFT administration can improve the prognosis of EGFR mutation-negative LUAD but not EGFR mutation-positive LUAD. Thus, clinical trials of adjuvant-targeted therapy for EGFR mutation-positive stage IB LUAD should also be conducted in Japan.PMID:38105006 | DOI:10.5761/atcs.oa.23-00134 (Source: Annals of Thoracic and Cardiovascular Surgery)
Source: Annals of Thoracic and Cardiovascular Surgery - December 17, 2023 Category: Cardiovascular & Thoracic Surgery Authors: Masaya Aoki Ryo Miyata Go Kamimura Aya Harada Takeda Takayuki Suetsugu Keiko Mizuno Kazuhiro Ueda Source Type: research

Challenges in Robotic Lung Lobectomy through the Anterior Approach
CONCLUSION: Although no severe incidence of vascular injury was observed with the AA, complications related to the use of stapling devices were noted.PMID:38030280 | DOI:10.5761/atcs.oa.23-00146 (Source: Annals of Thoracic and Cardiovascular Surgery)
Source: Annals of Thoracic and Cardiovascular Surgery - November 29, 2023 Category: Cardiovascular & Thoracic Surgery Authors: Atsushi Osoegawa Miyuki Abe Michiyo Miyawaki Takashi Karashima Yohei Takumi Shinkichi Takamori Kenji Sugio Source Type: research